Imbing, Mark John .
HRN: 22-01-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2023
CEFTRIAXONE 1G (VIAL)
11/24/2023
11/30/2023
IV
800mg
OD
T/c CNS Infection
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes